Pradeep Bhide Set To Step Down As Board Member Of GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited has announced that Pradeep V. Bhide will step down as a board member, effective from January 7, 2025.
Srirama Raju Kapalli Appointed As CFO Of Nagarjuna Fertilizers & Chemicals
The Board of Directors of Nagarjuna Fertilizers and Chemicals Limited has appointed Srirama Raju Kapalli as the Chief Financial Officer (CFO) with effect from January 4, 2025.
Ex-Independent Director Parpia Resolves SEBI Case With Rs 21.45 Lakh Settlement
Manu M. Parpia, a former Independent Director of Nesco Limited, resolved a case of alleged disclosure violations with the Securities and Exchange Board of India (SEBI) by paying Rs 21.45 lakh in settlement charges.
Government Appoints Faiz Ahmed Kidwai As DGCA Director General And Ashutosh Agnihotri As FCI Chairman
The government has made key appointments in various ministries, including Faiz Ahmed Kidwai as Directorate General of Civil Aviation (DGCA) Director General and Ashutosh Agnihotri as Food Corporation of India (FCI) Chairman, effective January 5, 2025.
Amit Ganorkar Succeeds Neelesh Garg As MD & CEO Of TATA AIG General Insurance
TATA AIG General Insurance has appointed Amit Ganorkar as its new Managing Director and Chief Executive Officer (MD & CEO), effective January 1, 2025.
Global Offshore Services Reappoints Faisy Viju As Independent Director
The Board of Directors of Global Offshore Services Limited has reappointed Faisy Viju as the Independent Director with effect from January 10, 2025.
Vikram Shukla Joins Zydus Lifesciences As President Of Parenteral Operations
The Board of Directors of Zydus Lifesciences Limited has approved the appointment of Vikram Shukla as a President of Parenteral Operations and Senior Management Personnel (SMP), effective January 3, 2025.
Prithwish Banerji Succeeds Murari Ranganathan As Commercial Director Of Women’s Health, Metabolics & International Business At Abbott India
Prithwish Kumar Banerji has been appointed as Commercial Director of Women’s Health, Metabolics, and International Business at Abbott India Limited with effect from January 3, 2025.
Goldman Sachs Announces Alex Golten As New Chief Risk Officer
Goldman Sachs has appointed Alex Golten as its new Chief Risk Officer, effective January 1, 2025.
Nick Clegg Steps Down, Joel Kaplan Takes Over As Meta’s Global Affairs Chief
Meta Platforms announced Joel Kaplan as its new Chief Global Affairs Officer, succeeding Nick Clegg.
